FIMASARTAN PROTECT CARDIAC MYOCYTE DAMAGE IN ISCHEMIC HEART DISEASES

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2017)

引用 0|浏览3
暂无评分
摘要
Background: The progressive cardiac dysfunction after myocardial infarction (MI) related with left ventricular fibrosis and remodeling. This study investigated whether new ARB ‘Fimasartan’ is able to protect in the post-MI progression of left ventricular (LV) dysfunction and unknown under lining
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要